Clin2
NCT07663825Possibly a fitNot yet recruiting

Aspirin to prevent painful blood clots in children with vein malformations

Venous Malformation, Low FlowVenous Malformations

Part of Blood & lymphatic clinical trials.

This trial tests whether adding aspirin to standard care can reduce the number of painful blood clots in children with a specific vein condition. It may help lower the frequency of these episodes and improve quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
34 people
Ages
6 years to 17 years
Study type
Interventional

Who can take part

  • Be between 6 and 17 years old
  • Weigh at least 20 kg (about 44 pounds)
  • Have a confirmed superficial vein malformation with a history of blood clots (at least 2 in the last year)
  • Be willing to take the study medication daily for several months
  • If you are a female who could become pregnant, you must use reliable birth control
  • Not have other serious medical conditions (like kidney, liver, or heart problems) or take certain blood-thinning medicines

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06729034Not yet recruiting· Phase 2
Blood thinner for painful venous malformations

This trial tests an oral blood thinner (a type of drug called a direct oral anticoagulant) to see if it can reduce pain and improve quality of life in people with painful venous malformations. The drug may help by preventing abnormal blood clotting inside the malformation.

Oslo
NCT05198960Recruiting· Phase 3
Blood thinner drugs vs aspirin to prevent clot problems

This trial compares apixaban or rivaroxaban (blood thinners) against aspirin to prevent future clot-related complications in people with certain bone marrow diseases (PV, ET, or pre-PMF) that have a specific JAK2 mutation. It may help lower the risk of clots, but it also carefully considers bleeding risk.

Angers
NCT03244020Enrolling by invitation· Phase 4
Aspirin or low-dose blood thinner after bone or leg surgery

This trial compares aspirin versus a low-dose injectable blood thinner (LMWH) to prevent blood clots after certain orthopedic cancer surgeries. It may help lower the risk of dangerous clotting while balancing bleeding and side effects.

Los Angeles, California
NCT05735639Recruiting· Phase 4
Prevention of blood clots during varicose vein treatment

This trial tests whether giving medicine to prevent blood clots during varicose vein treatment is safe and helpful. It focuses on people having a minimally invasive procedure on enlarged leg veins under local anesthesia.

London
NCT06494878Recruiting· Phase 3
Aspirin after childbirth to prevent blood clots

This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.

Brussels
NCT06780462Recruiting· Phase 3
Steroids with or without blood thinners for Behçet's vein clots

This trial tests whether adding a blood thinner (anticoagulant) to steroid therapy is more effective than steroids alone for treating deep vein thrombosis (a blood clot in a large vein) in people with Behçet's syndrome. It aims to find the best way to prevent future clots and reduce side effects.

Bordeaux

Hear when a new Venous Malformation, Low Flow trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.